Avid Bioservices Q1 Reports Fall Short of Analyst Expectations Despite Higher Revenue

Avid Bioservices Falls Short of Analyst Expectations with Quarterly Report

Avid Bioservices (NASDAQ: ) has released its Q1 report, and it seems to have missed the mark when it comes to meeting analyst expectations. Despite this setback, the company still managed to achieve higher revenue than anticipated. According to information published on Thursday, Avid Bioservices’ earnings per share (EPS) stood at $-0.03, coupled with a revenue of $37.7M.

These figures were slightly lower than what Investing.com had previously predicted. The platform estimated an EPS of $-0.02 per share on earnings of $37.06M for the company. Consequently, Avid Bioservices’ shares experienced a decline of 1.98%, falling to $11.39 after hours.

The healthcare sector of the NASDAQ stock market has seen other companies reporting earnings throughout this month. Novo Nordisk ADR previously announced second-quarter earnings of $1.28 per share on revenue of $8.03B. These figures were slightly lower than the expectations of $1.28 per share and revenue of $8.21B.

On the other hand, Medtronic managed to surpass analysts’ expectations with its latest report. The company’s first-quarter earnings of $1.2 per share and revenue of $7.7B exceeded projections. However, Investing.com had anticipated slightly lower figures, with an expected earnings per share of $1.11 on revenue of $7.57B.

For more updates on company earnings, be sure to check out Investing.com’s Earnings Calendar.

(Please note: The original text contained some grammatical errors, which have been corrected in this rewritten version.)

Investing.com – Avid Bioservices (NASDAQ: ) Q1 reports missed analyst expectations. with revenue higher than expected According to information published on Thursday.

Avid Bioservices’ earnings per share (EPS) were $-0.03 on revenue of $37.7M. Investing.com previously saw the figure at $-0.02 per share on earnings of $37.06M.

Avid Bioservices shares were down 1.98% to $11.39 after hours. After the earnings report

In addition to Avid Bioservices, there are other companies. in the healthcare sector of the NASDAQ stock market that reported earnings during this month

Novo Nordisk ADR previously reported second-quarter earnings of $1.28 per share on revenue of $8.03B, compared with expectations of $1.28 and revenue of $8.21B.

Although Medtronic’s performance based on the latest report exceeded analysts’ expectations, First quarter earnings of $1.2 per share and revenue of $7.7B beat analysts’ expectations. Investing.com It expects earnings per share to be around $1.11 on revenue of $7.57B.

Stay up-to-date with company earnings Investing.com Earnings Calendar

#Bioservices #Avid #Earnings #Beat #Expectations #Revenue #Beat #Expectations #Investing.com